ZOMDF · Zomedica Corp. · Insider Trading

$0.08 +0.01 (+6.46%) At close · Oct 5

Market Cap

$73.50M

979.95M

Volume · Oct 5 1.88M Avg daily vol (3M) 758.43K

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.

Query insider transactions through the insider trading API or MCP →

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-08-05	Blair Anthony K	COO	Award↑ Filing footnotes — Options to buy Common Stock (Direct) one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 8/4/2030	Options to buy Common Stock	500,000	—	—	500,000
2026-08-05	Klass Russell Kevin	Sr Vice President, Sales	Award↑ Filing footnotes — Options to buy Common Stock (Direct) one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 8/4/2030	Options to buy Common Stock	250,000	—	—	250,000
2026-08-05	DeHaan-Fullerton Karen	General Counsel	Award↑ Filing footnotes — Options to buy Common Stock (Direct) one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 8/4/2030	Options to buy Common Stock	250,000	—	—	250,000
2025-11-17	Cohen Robert	Director	Award↑	Stock Appreciation Right	1,823,107	—	—	1,823,107
2025-11-17	POWERS JOHNNY D	Director	Award↑	Stock Appreciation Right	1,823,107	—	—	1,823,107
2025-11-17	Williams Rodney James	Director	Award↑	Stock Appreciation Right	1,975,033	—	—	1,975,033
2025-11-17	Whelan Sean	Director	Award↑	Stock Appreciation Right	1,975,033	—	—	1,975,033
2025-11-17	MACLEOD CHRISTOPHER ROSS	Director	Award↑	Stock Appreciation Right	1,823,107	—	—	1,823,107
2025-11-17	Rowe Jeffrey M	Director	Award↑	Stock Appreciation Right	2,126,959	—	—	2,126,959
2025-11-17	Nichols Pamela	Director	Award↑	Stock Appreciation Right	1,823,107	—	—	1,823,107
2025-11-13	Klass Russell Kevin	Sr Vice President, Sales	Buy↑	Common Stock, without par value	150,000	$0.10	$14,550	5,784,101
2025-11-10	Klass Russell Kevin	Sr Vice President, Sales	Buy↑	Common Stock, without par value.	120,000	$0.10	$11,760	5,634,101
2025-11-07	Klass Russell Kevin	Sr Vice President, Sales	Buy↑	Common Stock, without par value	5,000	$0.10	$475	5,514,101
2025-11-06	Klass Russell Kevin	Sr Vice President, Sales	Buy↑	Common Stock, without par value	253,007	$0.08	$20,241	5,509,101
2025-08-12	Klass Russell Kevin	Sr Vice President, Sales	Buy↑	Common Stock, without par value	250,000	$0.04	$10,000	4,510,753
2025-08-12	Klass Russell Kevin	Sr Vice President, Sales	Buy↑	Common Stock, without par value	745,341	$0.04	$29,814	5,256,094
2025-08-11	Klass Russell Kevin	Sr Vice President, Sales	Buy↑	Common Stock, without par value	60,723	$0.04	$2,429	4,260,753
2025-08-11	Klass Russell Kevin	Sr Vice President, Sales	Buy↑	Common Stock, without par value	250,000	$0.04	$10,000	4,200,030
2025-08-11	Klass Russell Kevin	Sr Vice President, Sales	Buy↑	Common Stock, without par value	250,000	$0.04	$9,500	3,950,030
2025-08-08	Klass Russell Kevin	Sr Vice President, Sales	Buy↑	Common Stock, without par value	500,000	$0.04	$20,000	3,700,030
2025-06-12	Klass Russell Kevin	Sr Vice President, Sales	Award↑ Filing footnotes — Options to buy Common Stock (Direct) One quarter (1/4) of the options vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 06/11/2029	Options to buy Common Stock	500,000	—	—	500,000
2025-06-12	Blair Anthony K	COO	Award↑ Filing footnotes — Options to buy Common Stock (Direct) One quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 06/11/2029.	Options to buy Common Stock	750,000	—	—	750,000
2025-06-12	HEATON LARRY C II	Director, CEO	Award↑ Filing footnotes — Options to buy Common Stock (Direct) one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 6/11/2029	Options to buy Common Stock	4,000,000	—	—	4,000,000
2025-06-12	DeHaan-Fullerton Karen	General Counsel	Award↑ Filing footnotes — Options to buy Common Stock (Direct) one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 6/11/2029	Options to buy Common Stock	500,000	—	—	500,000
2025-05-21	Blair Anthony K	COO	Buy↑	Common Stock, without par value	63,750	$0.05	$3,188	1,000,000
2025-05-21	Blair Anthony K	COO	Buy↑	Common Stock, without par value	36,250	$0.05	$1,776	936,250
2025-05-19	DeHaan-Fullerton Karen	General Counsel	Buy↑	Common Stock, without par value	104,300	$0.05	$5,006	104,300
2025-05-19	POWERS JOHNNY D	Director	Buy↑	Common Stock, without par value	500,000	$0.05	$23,000	3,425,000
2025-03-17	Rowe Jeffrey M	Director	Buy↑ Filing footnotes — Common Stock, without par value (Indirect) Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust.	Common Stock, without par value (I)	100,647	$0.07	$7,045	1,540,127
2025-03-17	POWERS JOHNNY D	Director	Buy↑	Common Stock, without par value	50,000	$0.07	$3,350	2,825,000
2025-03-17	Rowe Jeffrey M	Director	Buy↑ Filing footnotes — Common Stock, without par value (Indirect) Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust.	Common Stock, without par value (I)	500,000	$0.06	$32,000	1,439,480
2025-03-17	Jordan Scott	Chief Business Officer	Buy↑	Common Stock, without par value	300,000	$0.06	$18,600	300,000
2025-03-17	Rowe Jeffrey M	Director	Buy↑ Filing footnotes — Common Stock, without par value (Indirect) Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust.	Common Stock, without par value (I)	34,725	$0.07	$2,465	2,378,485
2025-03-17	Rowe Jeffrey M	Director	Buy↑ Filing footnotes — Common Stock, without par value (Indirect) Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust.	Common Stock, without par value (I)	4,265	$0.07	$299	2,343,760
2025-03-17	Williams Rodney James	Director	Buy↑	Common Stock, without par value	100,000	$0.07	$6,900	100,000
2025-03-17	HEATON LARRY C II	Director, CEO	Buy↑	Common Stock, without par value	10,000	$0.05	$540	510,000
2025-03-17	POWERS JOHNNY D	Director	Buy↑	Common Stock, without par value	50,000	$0.07	$3,500	2,575,000
2025-03-17	POWERS JOHNNY D	Director	Buy↑	Common Stock, without par value	100,000	$0.07	$6,900	2,525,000
2025-03-17	HEATON LARRY C II	Director, CEO	Buy↑	Common Stock, without par value	118,855	$0.06	$6,894	628,855
2025-03-17	POWERS JOHNNY D	Director	Buy↑	Common Stock, without par value	100,000	$0.07	$6,700	2,675,000
2025-03-17	MACLEOD CHRISTOPHER ROSS	Director	Buy↑	Common Stock, without par value	143,000	$0.06	$8,437	143,000
2025-03-17	POWERS JOHNNY D	Director	Buy↑	Common Stock, without par value	100,000	$0.07	$6,700	2,775,000
2025-03-17	HEATON LARRY C II	Director, CEO	Buy↑	Common Stock, without par value	191,817	$0.06	$11,509	820,672
2025-03-17	Klass Russell Kevin	Sr Vice President, Sales	Buy↑	Common Stock, without $0.070 par value	699,980	$0.07	$48,999	3,200,030
2025-03-17	Williams Rodney James	Director	Buy↑ Filing footnotes — Common Stock, without par value (Direct) A correction is being made to the Form K filed on 3/18/2025 to add shares previously held by Mr. Williams and correct total securities beneficially owned following the transaction	Common Stock, without par value	100,000	$0.07	$6,900	261,900
2025-03-17	POWERS JOHNNY D	Director	Buy↑	Common Stock, without par value	100,000	$0.07	$6,500	2,925,000
2025-03-17	HEATON LARRY C II	Director, CEO	Buy↑	Common Stock, without par value	179,328	$0.06	$10,760	1,000,000
2025-03-17	Rowe Jeffrey M	Director	Buy↑ Filing footnotes — Common Stock, without par value (Indirect) Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust.	Common Stock, without par value (I)	731,368	$0.07	$49,733	2,399,495
2025-03-17	Blair Anthony K	COO	Buy↑	Common Stock, without par value	500,000	$0.06	$30,000	900,000
2025-03-17	Rowe Jeffrey M	Director	Buy↑ Filing footnotes — Common Stock, without par value (Indirect) Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust.	Common Stock, without par value (I)	68,000	$0.07	$4,556	1,608,127

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–50 of 180 transactions

Key facts CIK 1684144 CUSIP 98980M109 Visit website Investor relations